Nanoparticles for Drug and Gene Delivery in Treating Diseases of the Eye - Ocular Pharmacology and Toxicology - page 310

29. McCrackin FL (1987) Relationship of intrinsic
viscosity of polymer solutions to molecular
weight. Polymer 28(11):1847-1850
30. Wang N, Wu XS, Lujan-Upton H, Donahue E,
Siddiqui A (1997) Synthesis, characterization,
biodegradation, and drug delivery application
of biodegradable lactic/glycolic acid oligo-
mers: I synthesis and characterization. J Bioma-
ter Sci Polym Ed 8(12):905-917
31. Dawes GJ, Fratila-Apachitei LE, Necula BS,
Apachitei I, Witkamp GJ, Duszczyk J (2010)
Release of PLGA-encapsulated dexamethasone
from microsphere loaded porous surfaces. J
Mater Sci Mater Med 21(1):215-221. doi: 10.
1007/s10856-009-3846-6
32. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar
MN (2007) Estradiol loaded PLGA nanoparti-
cles for oral administration: effect of polymer
molecular weight and copolymer composition
on release behavior in vitro and in vivo. J Con-
trol Release 119(1):77-85. doi: 10.1016/j.
jconrel.2007.01.016
33. Wischke C, Schwendeman SP (2008) Princi-
ples of encapsulating hydrophobic drugs in
PLA/PLGA microparticles. Int J Pharm 364
(2):298-327.

(1-2):19-34. doi: 10.1016/j.ijpharm.2003.

08.020
40. Makadia HK, Siegel SJ (2011) Poly Lactic-co-
Glycolic Acid (PLGA) as Biodegradable Con-
trolled Drug Delivery Carrier. Polymers 3
(3):1377-1397. doi: 10.3390/polym3031377
41. Vert M, Mauduit J, Li S (1994) Biodegradation
of PLA/GA polymers: increasing complexity.
Biomaterials 15(15):1209-1213
42. Yandrapu S, Kompella UB (2013) Develop-
ment of sustained-release microspheres for the
delivery of SAR 1118, an LFA-1 antagonist
intended for the treatment of vascular compli-
cations of the eye. J Ocul Pharmacol Ther 29
(2):236-248. doi: 10.1089/jop.2012.0210
43. Tracy MA, Ward KL, Firouzabadian L, Wang
Y, Dong N, Qian R, Zhang Y (1999) Factors
affecting the degradation rate of poly(lactide-
co-glycolide) microspheres in vivo and in vitro.
Biomaterials 20(11):1057-1062
44. Houchin ML, Topp EM (2008) Chemical deg-
radation of peptides and proteins in PLGA: a
review of reactions and mechanisms. J Pharm
Sci 97(7):2395-2404. doi: 10.1002/jps.

21176
45. Chu CC (1981) The in-vitro degradation of
poly(glycolic acid) sutures—effect of pH. J
Biomed Mater Res 15(6):795-804. doi: 10.
1002/jbm.820150604
46. Dunne M, Corrigan I, Ramtoola Z (2000)
Influence of particle size and dissolution con-
ditions on the degradation properties of poly-
lactide-co-glycolide particles. Biomaterials 21
(16):1659-1668
47. Jain A, Jain SK (2013) Formulation and opti-
mization of temozolomide nanoparticles by 3
factor 2 level factorial design. Biomatter 3(2)
48. Julienne MC, Alonso MJ, Gomez Amoza JL,
Benoit JP (1992) Preparation of poly( DL lac-
tide/glycolide) nanoparticles of controlled par-
ticle size distribution: application of
experimental designs. Drug Dev Ind Pharm
18(10):1063-1077.

doi: 10.1016/j.ijpharm.2008.

04.042
34. Kenley RA, Maryann Ott Lee T, Randolph
Mahoney II, Sanders LM (1987) Poly(lactide-
co-glycolide) decomposition kinetics in vivo
and in vitro. Macromolecules 20

(10):2398-2403
35. Wang N, Wu XS (1997) Synthesis, characteri-
zation, biodegradation, and drug delivery
application of biodegradable lactic/glycolic
acid oligomers: Part II Biodegradation and
drug delivery application.

J Biomater Sci

Polym Ed 9(1):75-87
36. Park TG (1995) Degradation of poly(lactic-co-
glycolic acid) microspheres: effect of copoly-
mer composition. Biomaterials 16

(15):1123-1130
37. Jalil R, Nixon JR (1990) Microencapsulation
using poly ( L -lactic acid) III: effect of polymer
molecular weight on the microcapsule proper-
ties. J Microencapsul 7(1):41-52. doi: 10.
3109/02652049009028422
38. Beck LR, Pope VZ, Flowers CE Jr, Cowsar
DR, Tice TR, Lewis DH, Dunn RL, Moore
AB, Gilley RM (1983) Poly( DL -lactide-co-gly-
colide)/norethisterone microcapsules: an
injectable biodegradable contraceptive. Biol
Reprod 28(1):186-195
39. Braunecker J, Baba M, Milroy GE, Cameron
RE (2004) The effects of molecular weight and
porosity on the degradation and drug release
from polyglycolide.

doi: 10.3109/

03639049209069315
49. Gomez-Gaete C, Bustos GL, Godoy RR, Saez
CK, Novoa GP, Fernandez EM, Tsapis N, Fat-
tal E (2013) Successful factorial design for the
optimization of methylprednisolone encapsula-
tion in biodegradable nanoparticles. Drug Dev
Ind Pharm 39(2):310-320. doi: 10.3109/
03639045.2012.676049
50. Lalani J, Rathi M, Lalan M, Misra A (2013)
Protein functionalized tramadol-loaded PLGA
nanoparticles: preparation, optimization, sta-
bility and pharmacodynamic studies. Drug
Dev Ind Pharm 39(6):854-864. doi: 10.
3109/03639045.2012.684390

Int J Pharm 282